Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. Total Liabilities 2014–2025
Aytu BioPharma Inc. annual total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aytu BioPharma Inc. total liabilities as of June 30, 2025: 105.2M, a 16.41% increase year-over-year.
- Aytu BioPharma Inc. total liabilities for 2025 were 105.2M, a 16.41% increase from 2024.
- Aytu BioPharma Inc. total liabilities for 2024 were 90.4M, a 6.93% decrease from 2023.
- Aytu BioPharma Inc. total liabilities for 2023 were 97.1M, a 4.06% increase from 2022.
- Aytu BioPharma Inc. total liabilities for 2022 were 93.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aytu BioPharma Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $105 |
| 2024 | $90 |
| 2023 | $97 |
| 2022 | $93 |
| 2021 | $128 |
| 2020 | $58 |
| 2019 | $28 |
| 2018 | $8 |
| 2017 | $11 |
| 2016 | $14 |
| 2015 | $3 |
| 2014 | $7 |
Aytu BioPharma Inc. Total Liabilities — FAQ
Aytu BioPharma Inc. (AYTU) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AYTU's total liabilities history?
The chart and table above show Aytu BioPharma Inc.'s total liabilities by year and by quarter, including the growth rate.